Avexima is a full cycle pharmaceutical company

We use modern technologies for the synthesis of pharmaceutical substances and the production of medications.

Our goals

We aim to become one of the acknowledged leaders in the field for effectiveness which is measured not only by the numbers and percentages, but people's fates and smiles.

Our values

We appreciate progressiveness in everything, trustworthiness in every deed and effectiveness in every action.

Our mission

We take all measures to ensure that there are as few ill people as possible and that they recover as soon as possible, live a full-fledged life and enjoy every day.

Our dream is the world without incurable diseases.

We believe that only those who take the responsibility, keep up with the progress and mainstream new technologies can really help people.

Our values

value-01

Innovation

in every action

We invest our efforts and resources in research activities, development of new technologies to develop new effective drug products and launch industrial manufacturing.

value-02

Responsibility

in every deed

We proudly bear the responsibility for public health by closely monitoring the development process as well as test and manufacturing stages to ensure the quality of drug products.

value-03

Efficiency

in everything

We effectively build business processes, upgrade and create modern drug manufacturing processes. We also manufacture high demand drug products of various pharmaceutical groups.

Only those who take the responsibility, keep up with the progress and mainstream new technologies can really help people.

Please note. The brand name has changed.
Look for Bromcamphora in pharmacies under the name of «Dobrocam».

News

04.04.2023

Nobazit® - new indications for use

On March 28, 2023, within the framework of the XV Annual All-Russian Congress on Infectious Diseases named after the Academician V.I. Pokrovsky, a symposium was held on the viral diseases treatment current issues, entitled “Universal Approaches to the Therapy of Respiratory Viral Infections during the COVID-19 Pandemic.”

16.03.2023

Visit of the Kemerovo Oblast – Kuzbass Governor to the “Avexima Siberia” LLC, Pharmaceutical Plant

The Kemerovo Oblast – Kuzbass Governor, Sergey Tsivilev, visited the “Avexima Siberia” LLC, Chemical and Pharmaceutical Plant in Anzhero-Sudzhensk town.

27.12.2022

Antiviral drug “Nobazit” from “Avexima”, the Russian pharmaceutical company, at the main musical event of the year – the National Music Award “Golden Gramophone”.

The modern antiviral drug “Nobazit” has become the official sponsor of the National Music Award “Golden Gramophone”, which took place on December 10, 2022. As a gift from the sponsor, the singer and composer Dmitry Malikov received a supply of the antiviral drug “Nobazit”.

02.11.2022

FURACILIN AVEXIMA New Packaging Release

The “Avexima”, OJSC, Pharmaceutical Company, informs you about the release of FURACILIN AVEKSIMA effervescent tablets No. 20 (5 strips of 4 tablets each) on the market in October 2022.

All news